The World Trade Organization was expected to meet the past week to consider a proposal that has been languishing for the past year: a temporary waiver of pharmaceutical intellectual property during the pandemic to allow poor countries to make many of the same tests, treatments, and vaccines that rich countries have had throughout the pandemic. Yet in a cruel reminder of the urgency of the problem,...
